Related Experiment Video
Updated: Nov 30, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
Establishment of a Colorectal Cancer-Related MicroRNA-mRNA Regulatory Network by Microarray and Bioinformatics
Dan Jiang1,2, Xiaoliang Xie1,3, Zhenhui Lu1,4
1School of Clinical Medicine, Ningxia Medical University, Yinchuan, China.
Abstract:
Colorectal cancer (CRC) is one of the most malignant cancers with high morbidity and mortality. MicroRNAs (miRNAs) are small non-coding RNAs that affect biological processes by binding to mRNAs and regulating their expression, and epigenetic alterations including miRNA dysregulation are significantly involved in CRC development. Determining the effect of the miRNA-mRNA network on CRC could be helpful for developing novel therapeutic targets and prognostic biomarkers, and even improving survival. In this study, microarray assays were used to screen differentially expressed miRNAs (DE miRNAs) and mRNAs (DE mRNAs) in CRC and the adjacent normal tissues. Among the detected genes, 42 miRNAs and 142 mRNAs were significantly upregulated in CRC, while 23 miRNAs and 279 mRNAs were significantly downregulated. Through overlapping of predicted targets of DE miRNAs and anti-expressed DE mRNAs, networks of DE miRNAs and DE mRNAs in CRC were established. Additionally, the formation of a protein-protein interaction network of DE mRNAs possibly targeted by DE miRNAs, functional annotation and pathway analysis, stable subnetwork mining, and determination of hub genes provided the probable mechanism used by DE miRNAs and DE mRNAs to regulate CRC growth. Finally, validation of expression and prognostic potential of hub genes provided further support for the results above and indicated that CCL-28, GPR15, PNOC, NUSAP1, and their interacted miRNAs may be a potential signature for prognosis of CRC patients. In sum, we successfully established miRNA-mRNA regulatory networks based on microarray results targeting CRC, and these findings may elucidate the mechanisms used for CRC growth and identify miRNA-related signatures for prognosis and treatment of CRC.
Insights
This study identifies key microRNA-messenger RNA networks involved in colorectal cancer (CRC) development. These findings highlight potential prognostic biomarkers and therapeutic targets for improving CRC patient outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Colorectal cancer (CRC) presents significant global health challenges due to high morbidity and mortality.
- MicroRNA (miRNA) dysregulation is implicated in CRC pathogenesis, influencing gene expression.
- Understanding miRNA-mRNA interactions is crucial for identifying novel therapeutic strategies and biomarkers for CRC.
Purpose of the Study:
- To establish miRNA-mRNA regulatory networks in colorectal cancer.
- To identify differentially expressed miRNAs (DE miRNAs) and mRNAs (DE mRNAs) in CRC tissues.
- To explore the potential of identified genes and miRNAs as prognostic biomarkers for CRC.
Main Methods:
- Microarray assays were employed to screen for DE miRNAs and DE mRNAs in CRC and adjacent normal tissues.
- Bioinformatic analyses were used to construct miRNA-mRNA networks, protein-protein interaction networks, and identify hub genes.
- Expression and prognostic potential of selected hub genes were validated.
Main Results:
- Significant numbers of miRNAs and mRNAs were found to be upregulated and downregulated in CRC tissues.
- Established miRNA-mRNA networks revealed potential regulatory mechanisms in CRC growth.
- Hub genes, including CCL-28, GPR15, PNOC, and NUSAP1, along with their interacting miRNAs, showed prognostic potential for CRC patients.
Conclusions:
- MiRNA-mRNA regulatory networks were successfully constructed for colorectal cancer using microarray data.
- The identified networks and hub genes offer insights into CRC development mechanisms.
- Specific miRNA-gene signatures may serve as valuable prognostic and therapeutic targets for CRC.
Related Concept Videos
MicroRNAs
MicroRNAs

